Biddle Warner Weston bought KYTX
March 13, 2026 · Form 4 insider transaction
Biddle Warner Weston bought 58,000 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
58,000
Price
$0.00
Total value
N/A
InsiderBiddle Warner Weston
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after58,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.